Get the Stockscreener App
119.90
1.39%
-1.69
After Hours:
119.97
0.07
+0.06%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $119.90, with a volume of 360.06K.
It is down -1.39% in the last 24 hours and down -1.27% over the past month.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
See More
Previous Close:
$121.59
Open:
$122.16
24h Volume:
360.06K
Relative Volume:
0.43
Market Cap:
$5.41B
Revenue:
$3.03B
Net Income/Loss:
$237.44M
P/E Ratio:
23.84
EPS:
5.03
Net Cash Flow:
$450.04M
1W Performance:
+0.27%
1M Performance:
-1.27%
6M Performance:
-34.03%
1Y Performance:
-43.29%
1-Day Range:
$119.79
$122.39
1-Week Range:
$117.41
$123.97
52-Week Range:
$115.94
$249.91
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
119.90 | 5.41B | 3.03B | 237.44M | 450.04M | 5.03 |
|
ISRG
Intuitive Surgical Inc
|
544.47 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
176.16 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.78 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.96 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.26 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Teleflex stock hits 52-week low at 118.66 USD - Investing.com
Teleflex stock hits 52-week low at 118.66 USD By Investing.com - Investing.com Nigeria
Former Teleflex Executive Joins Imperative Care’s Board - Medical Product Outsourcing
Teleflex Study Shows 70.5% Reduction in CLABSI with Antimicrobial CVCs - MSN
Teleflex Launches Awareness Initiatives for Men’s Health Month - MSN
Teleflex has positive Arrow catheter data - MassDevice
Teleflex (TFX) Study Shows Significant Reduction in CLABSIs with Impregnated Catheters | TFX Stock News - GuruFocus
New Prospective Cohort Study Reporting the Efficacy of - GlobeNewswire
Wealth Enhancement Advisory Services LLC Has $592,000 Stock Holdings in Teleflex Incorporated (NYSE:TFX) - Defense World
Teleflex Releases 2024 Global Impact Report, Showcasing CSR Progress - MSN
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month - The Manila Times
Teleflex Highlights Prostate Health and Quality-of-Life - GlobeNewswire
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month - Yahoo Finance
Teleflex (TFX) Fell on Spin-Off Announcements - Insider Monkey
Nasal Atomizer Devices Market Projected to Witness Massive GrowthTeleflex Incorporated, DeVilbiss Healthcare - openPR.com
Strategy To YieldBoost Teleflex To 22.1% Using Options - Nasdaq
Medical Cannula Market Is Booming WorldwideSmiths Medical, Teleflex - openPR.com
TFX ALERT: Ongoing Investigation Into Teleflex IncorporatedContact Levi & Korsinsky - ACCESS Newswire
Teleflex Incorporated (NYSE:TFX) Shares Bought by Ameriprise Financial Inc. - Defense World
Jane Street Group LLC Cuts Stock Position in Teleflex Incorporated (NYSE:TFX) - Defense World
Teleflex Incorporated: Breaking New Ground with Strategic NewCo Spin-Off to Unlock Hidden Value But What Lies Ahead? - Smartkarma
Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of “Hold” from Analysts - Defense World
Teleflex stock hits 52-week low at $120 amid 41.8% annual drop By Investing.com - Investing.com South Africa
Teleflex stock hits 52-week low at $120 amid 41.8% annual drop - Investing.com Australia
Teleflex Incorporated Announcement: If You Have Suffered - GlobeNewswire
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: ... - Eagle-Tribune
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: TFX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Fortis Hospital partners with Teleflex in India to launch UroLift Centre of Education - Medical Dialogues
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE - Bluefield Daily Telegraph
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Compass Diversified Holdings Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
Teleflex Highlights UroLift™ System’s Clinical Advantages at 2025 AUA Meeting - MSN
Surgical Clips Market Is Booming Worldwide 2025-2032 | Teleflex Incorporated,B. Braun Melsungen AG - openPR.com
Teleflex Publishes 2024 Global Impact Report - GlobeNewswire
Fortis Hospitals partners with Teleflex to launch UroLift training center - Healthcare Radius
Fortis Hospitals Partners with Teleflex for Innovative UroLift Training Hub - Devdiscourse
Equities Analysts Offer Predictions for Teleflex Q3 Earnings - Defense World
Fortis Hospital Bengaluru signs MoU with Teleflex in India to create a UroLift Center of Education for South Asia - APN News
City hospital signs MoU with Teleflex to create a UroLift Center of Education for South Asia - The Hindu
Teleflex Expands its Irish Facility - Medical Product Outsourcing
Teleflex’s Third Quarter Numbers Are In - Medical Product Outsourcing
Teleflex: Cheap With Significant Unknowns (NYSE:TFX) - Seeking Alpha
Study Highlights Reduced Post-Operative GERD Rates Tied to Titan SGS Stapler in Sleeve Gastrectomy - MyChesCo
Teleflex Declares Quarterly Dividend of $0.34 per Share - MyChesCo
Teleflex's (NYSE:TFX) Dividend Will Be $0.34 - simplywall.st
Ex-Dividend Reminder: Bloomin' Brands, Teleflex and Concentra Group Holdings Parent - Nasdaq
Option-related insider selling at OR Royalties (OR) - The Globe and Mail
Teleflex Amends Bylaws to Ease Stockholder Actions - TipRanks
Read This Before Considering Teleflex Incorporated (NYSE:TFX) For Its Upcoming US$0.34 Dividend - simplywall.st
Gleiss Lutz advises Teleflex on regulatory aspects of the acquisition of the BIOTRONIK Group’s vascular intervention business - Gleiss Lutz
Teleflex (TFX) Showcases UroLift System's Clinical Efficacy at 2025 Urological Meeting | TFX Stock News - GuruFocus
Teleflex (NYSE:TFX) Is Paying Out A Dividend Of $0.34 - Yahoo Finance
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Teleflex Incorporated Stock (TFX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kelly Liam | Chairman, President & CEO |
Feb 19 '25 |
Option Exercise |
121.41 |
36,464 |
4,427,199 |
63,556 |
| Logue Daniel V. | CVP, General Counsel & Secty |
Feb 20 '25 |
Option Exercise |
121.00 |
1,620 |
196,020 |
14,328 |
| Klasko Stephen K. M.D. | Director |
Feb 20 '25 |
Option Exercise |
121.00 |
2,674 |
323,554 |
9,827 |
| RANDLE STUART A | Director |
Aug 16 '24 |
Option Exercise |
121.00 |
2,674 |
323,554 |
8,170 |
| RANDLE STUART A | Director |
Aug 16 '24 |
Sale |
238.93 |
2,674 |
638,899 |
5,496 |
0.32%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):